SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Senior who wrote (41792)3/16/2011 1:21:21 PM
From: E_K_S  Read Replies (1) of 79000
 
Hi Paul -
Re: Johnson & Johnson (JNJ)

My Drug Company watch list was looking interesting today. Specifically MRK under $30.00/share may present a good buying opportunity. I added JNJ to the list based on your post. I pretty much stopped watching it since they have had so many quality production issues. My last transaction was 12/2009 where I closed out my position at $64.00/share.

Buffet still maintains his holdings in the company w/ the 4th largest individual position.

Johnson & Johnson (JNJ) Stock Holdings Summary (Ownership)
As of 12/31/2010
nasdaq.com

STATE STREET CORP 	        12/31/2010 	138,223,181 	2,619,253 	1.93% 	$8,083,292
VANGUARD GROUP INC 12/31/2010 103,063,329 (409,900) (0.40%) $6,027,143
BARCLAYS GLOBAL INVE... 12/31/2010 70,860,571 1,126,303 1.62% $4,143,926
BERKSHIRE HATHAWAY I... 12/31/2010 42,624,563 0 0.00% $2,492,684
BANK OF NEW YORK MEL... 12/31/2010 40,847,705 248,680 0.61% $2,388,774


FWIW, "Value Cruncher" ( valuecruncher.com ) has a value of $86.84/share for Johnson & Johnson (JNJ). Is the stock really 48% undervalued? ( I doubt it).

EKS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext